Dr. Hsien-Hsien Lei is Chief Executive Officer (CEO) of The American Chamber of Commerce (AmCham) in Singapore — the largest and the most active international business association in Singapore and Southeast Asia, with over 6,000 members representing over 600 companies. Hsien is also an Adjunct Associate Professor at the National University of Singapore Saw Swee Hock School of Public Health.
Prior to AmCham, Hsien was Vice President, Medical and Scientific Affairs, Medtronic Asia Pacific, where she was responsible for the Medtronic Innovation Centers in Japan and Korea, training and education, and the company’s health systems transformation strategy in the region. Hsien also has extensive experience in corporate communications, advertising and promotion, and government affairs.
Professor Dame Carol Black is currently Chair of the British Library, the Centre for Ageing Better, and Think Ahead, the Government’s fast-stream training programme for Mental Health Social Workers. She chairs NHS Improvement’s Advisory Board on Employee Health and Wellbeing, and is Adviser to NHSI and PHE on Health and Work. She is also a member of RAND Europe’s Council of Advisers, and of the Board of UKActive. She recently completed her seven-year term as Principal of Newnham College Cambridge, where she was a Deputy Vice-Chancellor. She still sits on the University’s Advisory Board for the Centre of Science and Public Policy, and the Strategy Board on Student Mental Health and Wellbeing. She is a Patron of the Women’s Leadership Centre in the Judge Business School. Dame Carol has completed three independent reviews for the UK Government: of the health of the working-age population in 2008 as National Director for Health and Work; of sickness absence in Britain in 2011 as co-chair; and of employment outcomes of addiction to drugs or alcohol, or obesity, in 2016. In February 2019 the Home Secretary announced that Dame Carol would lead an independent review on illicit drugs, demand, supply and treatment. Professor Black is a past-President of the Royal College of Physicians, of the Academy of Medical Royal Colleges, and of the British Lung Foundation, and past-Chair of the Nuffield Trust for health policy. The Centre she established at the Royal Free Hospital in London is internationally renowned for research and treatment of connective tissue diseases such as scleroderma. She has recently been a Trustee of the National Portrait Gallery.
Nawal Roy is the founder and CEO of Holmusk, bringing more than fifteen years of finance and consulting strategy experience to the helm of the company. Prior to this, Nawal was Co-Founder and CEO of HelloPay (Rocket Internet venture), and a Junior Partner at McKinsey & Company. He has served as a Steering Committee member (Value Based Health Care) for the World Economic Forum, and co-founded Galen Growth Asia – The Asia HealthTech Connector. Having enjoyed a global career spanning from New York to Tokyo, his close involvement with markets across North America, Europe, Southeast Asia, India AND China yields uniquely diverse experience in building next generation global companies.
Nawal carves out the strategic direction of Holmusk, leading from the front with round-the-clock hustle and infectious energy. Driving business development, partnerships, and growth, his mission is to build a company founded on the commitment to solving some of the world’s greatest challenges in healthcare.
Cheryl Liew helps ambitious, bold and purpose-driven business leaders and entrepreneurs excel in their career/business without compromising the lifestyle they desire - engaged, vibrant and fulfilling life.
As an advisor to C-suite, she partners with leaders to evolve a contemporary, inclusive and sustainable high performing work culture in an ever-changing business environment. Having a span of more than 20 years in the corporate arena across the different industries and in 4 different continents, she has held diverse senior leadership in and staff positions (in healthcare, education, retail, manufacturing, medi-care) before jumping into being an entrepreneur to build the legacy of enabling others to life an excellent life.
As the founder of The 24-Hour Woman, she guides passionate, courageous and purpose-driven women business leaders and entrepreneurs on their sustainable high performance living so that they can excel in their career/business whilst navigating work/life challenges.
She contributes to the community HR and Business Community as international speaker including ASTD, HRM Summit (2013, 2015), The Conference Board, Green Is the New Black: Consciousness Festival 2016, Working Mother Media’s Global Women Advancement Conference (2016, 2017) in Hong Kong and Singapore), Global Women Forum (2018, 2019) in Singapore and Paris) and being a subcommittee member of The Singapore Future Economy Study.
Ai Hua joined Johnson & Johnson more than 25 years ago with a desire to make a difference to the lives of patients. This passion continues today in her role as Company Group Chairman for Janssen Asia Pacific, where she oversees operations that deliver pharmaceutical innovation in Australia, China, Hong Kong, India, Japan, Korea, New Zealand and Taiwan.
Based in her native Singapore, Ai Hua is known for her deep commitment to customers and patients, her strategic insights and global mindset. She is a strong advocate for women in leadership and provides guidance and support through local universities and the Young Women’s Leadership Connection Mentorship Program.
In her previous role as President of One J&J Southeast Asia, Ai Hua was instrumental in the successful implementation of J&J’s first-ever one-company enterprise business model encompassing pharmaceuticals, consumer products and medical devices. She nurtured a business with strong growth and enhanced efficiency across 10 countries in ASEAN.
Ai Hua holds a BSc in Microbiology and Biochemistry and an MBA from the National University of Singapore. She began her healthcare career in 1991 as a product specialist with Johnson & Johnson Medical Singapore. Since then, she has held leadership roles in pharmaceuticals and medical devices working in strategic marketing, sales management, and licensing and acquisition while residing in Singapore, China and the USA.
Ai Hua is a committed volunteer for charitable causes and acts as chair of J&J’s Asia Pacific Contributions Committee. She is also a council member of the Singapore Dover Park Hospice, serves on the Advisory Board of the Singapore Management University Lee Kong Chian School of Business, and was recently appointed to the Board of the DesignSingapore Council.